Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma. Long-term survival in a prospective, non-randomized study

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 1, 2008, Pages 1-5

  Kessler, Peter ^a   Grabenbauer, Gerhard ^b   Leher, Anna ^b   Bloch Birkholz, Alexandra ^b   Vairaktaris, Elephtherios ^c   Neukam, Friedrich Wilhelm ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Long term survival; Oral squamous cell carcinoma; Tumour therapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MANDIBULAR NEOPLASMS; MIDDLE AGED; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT;

EID: 37249056438     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.08.006     Document Type: Article

References (23)

1. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
2. Bernier J., and Bentzen S.M. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. Eur J Cancer 39 (2003) 560-571
3. Fu K.K., Pajak T.F., Marcial V.A., et al. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys 32 (1995) 577-588
4. Fuchs S., Rodel C., Brunner T., et al. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma. Onkologie 26 (2003) 12-18
5. Garden A.S., Harris J., Vokes E.E., et al. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 22 (2004) 2856-2864
6. Herrmann T., Jakubek A., and Trott K.R. The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 170 (1994) 545-549
7. Kessler P., Bloch-Birkholz A., Leher A., et al. Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Radiother Oncol 70 (2004) 275-282
8. Kuhnt T., Becker A., Pigorsch S., et al. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlenther Onkol 179 (2003) 673-681
9. Mohr C., Bohndorf W., Carstens J., et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomised DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 23 (1994) 140-148
10. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94 (2002) 2967-2980
11. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analyses of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
12. Wanebo H., Chougule P., Ready N., et al. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 8 (2001) 644-650
13. Wendt T.G., Grabenbauer G.G., Rodel C.M., et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16 (1998) 1318-1324
14. Wiltfang J., Grabenbauer G., Bloch-Birkholz A., et al. Beurteilung der Lebensqualität von Patienten mit Plattenepithelkarzinomen der Mundhöhle. Vergleich von zwei Behandlungsstrategien in einer prospektiven Studie. (Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study-first results). Strahlenther Onkol 179 (2003) 682-689
15. Kies M.S., Haraf D.J., Rosen F., et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19 (2001) 1961-1969
16. Rosenthal D.I., Lee J.H., Sinard R., et al. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 19 (2001) 1363-1373
17. Fietkau R., Iro H., Grabenbauer G.G., et al. Simultane Radiochemotherapie mit Cisplatin und 5-FU bei fortgeschrittenen Kopf-Hals-Tumoren. (Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumours). Strahlenther Onkol 167 (1991) 693-700
18. Budach V., Stuschke M., and Budach W. Hyperfractionated accelerated chemoradiation with concurrent fluororuracil-mitomycin is more effective than dose-escalated hyperfractioanted accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
19. Dagum P., Pinto H.A., Newman J.P., et al. Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 176 (1998) 448-452
20. Grabenbauer G.G., Rödel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only?. Radiother Oncol 66 (2003) 57-63
21. Grabenbauer G.G., Suckorada O., Niedobitek G., et al. Imbalance between proliferation and apoptosis may be responsible for treatment failure after postoperative radiotherapy in squamous cell carcinoma of the oropharynx. Oral Oncol 39 (2003) 459-469
22. Suntharalingam M., Haas M.L., Conley B.A., et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 47 (2000) 49-56
23. Vokes E.E., Stenson K., Rosen F.R., et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21 (2003) 320-326